Adaptive Biotechnologies Corporation
Cash Flow Statement
| Line Item | FY2017 |
|---|---|
| Operating Activities | |
| Net Income | $-42.8M |
| Depreciation & Amortization | — |
| Depreciation | $4.1M |
| Amortization | $1.7M |
| Stock-Based Compensation | $7.0M |
| Net Cash from Operating Activities | $-34.9M |
| Investing Activities | |
| Capital Expenditures | $2.4M |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $36.4M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $50.0M |
| Net Change in Cash | $51.6M |
| Free Cash Flow | $-37.3M |